We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Warned for Issues at California Plant
Gilead Warned for Issues at California Plant
November 2, 2010
Gilead has received a warning letter from the FDA for manufacturing deficiencies at its San Dimas, Calif., facility where three of its biopharmaceuticals are manufactured.